The Effect of Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism on the Severity and Death Rate of COVID-19 in Iranian Patients

Overview

Journal Biochem Genet

Specialty Molecular Biology

Date 2023 Dec 25

PMID 38145438

Authors

Mohammad Samet

Mehran Yazdi

Masoud Tajamolian

Mahdi Beygi

Mohammad Hasan Sheikhha

Seyed Mehdi Hoseini

Affiliations

Soon will be listed here.

Abstract

The study was designed to assess the association of ACE I/D polymorphism with the severity and prognosis of COVID-19 in the Iranian population. Hence, 186 adult patients were categorized into three clinical groups based on the severity of COVID-19: 1) Outpatients or mildly symptomatic patients as control (n = 71); 2) Hospitalized patients or severe symptomatic cases (n = 53); 3) Inpatients led to ICU/death or critically ill patients needed mechanical ventilation (n = 62). The possible association of ACE I/D polymorphism with the risk of comorbidities and serum level of C-reactive protein was evaluated in two severe cases. The results showed that the frequency of D and I alleles are 69.35% and 30.65%, respectively, in the total population. The analysis of allelic frequencies via Fisher's exact test confirmed significantly higher frequency of D allele in both severe groups than that in the mild one, 78.31% in Hospitalized patients (OR = 2.56; 95% CI 1.46 to 4.46; p-value = 0.0011) and 74.19% in Inpatients led to ICU/death (OR = 2.04; 95% CI = 1.22 to 3.43; p-value = 0.0094) compared to 58.45% in Outpatients. The results of genotype proportions displayed an association between COVID-19 severity and DD genotype. Overall, our findings in Iranian patients supported the undeniable role of the DD genotype in the intensity of the disease, comparable to other populations. Furthermore, there is no definite evidence regarding the protective effect of the I allele in our inquiry.

References

Abraham W, Raynolds M, Gottschall B, Badesch D, Wynne K, GROVES B . Importance of angiotensin-converting enzyme in pulmonary hypertension. Cardiology. 1995; 86 Suppl 1:9-15. DOI: 10.1159/000176939. View

Aksoy H, Karadag A, Wollina U . Angiotensin II receptors: Impact for COVID-19 severity. Dermatol Ther. 2020; 33(6):e13989. PMC: 7361069. DOI: 10.1111/dth.13989. View

Ali N . Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19. J Med Virol. 2020; 92(11):2409-2411. PMC: 7301027. DOI: 10.1002/jmv.26097. View

Ali A, Alghasham A, Ismail H, Dowaidar M, Settin A . ACE I/D and eNOS E298D gene polymorphisms in Saudi subjects with hypertension. J Renin Angiotensin Aldosterone Syst. 2012; 14(4):348-53. DOI: 10.1177/1470320312459976. View

Arici M, Walls J . End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link?. Kidney Int. 2001; 59(2):407-14. DOI: 10.1046/j.1523-1755.2001.059002407.x. View

Babajani F, Kakavand A, Mohammadi H, Sharifi A, Zakeri S, Asadi S . COVID-19 and renin angiotensin aldosterone system: Pathogenesis and therapy. Health Sci Rep. 2021; 4(4):e440. PMC: 8596942. DOI: 10.1002/hsr2.440. View

Berge K, Berg K . Cardiovascular risk factors in people with different genotypes in the insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme (ACE). Clin Genet. 1998; 52(6):422-6. DOI: 10.1111/j.1399-0004.1997.tb02562.x. View

Calabrese C, Annunziata A, Coppola A, Pafundi P, Guarino S, Di Spirito V . ACE Gene I/D Polymorphism and Acute Pulmonary Embolism in COVID19 Pneumonia: A Potential Predisposing Role. Front Med (Lausanne). 2021; 7:631148. PMC: 7874110. DOI: 10.3389/fmed.2020.631148. View

Catarata M, Ribeiro R, Oliveira M, Cordeiro C, Medeiros R . Renin-Angiotensin System in Lung Tumor and Microenvironment Interactions. Cancers (Basel). 2020; 12(6). PMC: 7352181. DOI: 10.3390/cancers12061457. View

10.

Chen J, Wang R, Hozumi Y, Liu G, Qiu Y, Wei X . Emerging dominant SARS-CoV-2 variants. ArXiv. 2022; . PMC: 9603820. View

11.

Cobanogullari H, Unal Evren E, Evren H, Suer K, Balcioglu O, Ergoren M . Strong association between angiotensin-converting enzyme gene InDel polymorphism and COVID-19 diseases. Med Clin (Engl Ed). 2023; 160(11):489-494. PMC: 10250597. DOI: 10.1016/j.medcle.2022.11.020. View

12.

de Carvalho S, Simoes E Silva A, Sabino A, Evangelista F, Gomes K, Dusse L . Influence of ACE I/D Polymorphism on Circulating Levels of Plasminogen Activator Inhibitor 1, D-Dimer, Ultrasensitive C-Reactive Protein and Transforming Growth Factor β1 in Patients Undergoing Hemodialysis. PLoS One. 2016; 11(3):e0150613. PMC: 4811575. DOI: 10.1371/journal.pone.0150613. View

13.

Devaraj S, Xu D, Jialal I . C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation. 2003; 107(3):398-404. DOI: 10.1161/01.cir.0000052617.91920.fd. View

15.

Fang L, Karakiulakis G, Roth M . Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?. Lancet Respir Med. 2020; 8(4):e21. PMC: 7118626. DOI: 10.1016/S2213-2600(20)30116-8. View

16.

Faridzadeh A, Mahmoudi M, Ghaffarpour S, Zamani M, Hoseinzadeh A, Naghizadeh M . The role of ACE1 I/D and ACE2 polymorphism in the outcome of Iranian COVID-19 patients: A case-control study. Front Genet. 2022; 13:955965. PMC: 9483011. DOI: 10.3389/fgene.2022.955965. View

17.

Franco R, Lillo A, Rivas-Santisteban R, Rodriguez-Perez A, Reyes-Resina I, Labandeira-Garcia J . Functional Complexes of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Receptors: Expression in Adult but Not Fetal Lung Tissue. Int J Mol Sci. 2020; 21(24). PMC: 7766085. DOI: 10.3390/ijms21249602. View

18.

Gao J, Lin Y, Xiao Y, Xu K, Xu W, Zhu Y . Polymorphism of angiotensin-converting enzyme gene and genetic susceptibility to asthma with familial aggregation. Chin Med Sci J. 2003; 15(1):24-8. View

19.

Gemmati D, Tisato V . Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19. Genes (Basel). 2020; 11(9). PMC: 7563402. DOI: 10.3390/genes11091044. View

20.

Gintoni I, Adamopoulou M, Yapijakis C . The Impact of and Gene Polymorphisms in Pulmonary Diseases Including COVID-19. In Vivo. 2022; 36(1):13-29. PMC: 8765175. DOI: 10.21873/invivo.12672. View

21.

Gomez J, Albaiceta G, Garcia-Clemente M, Lopez-Larrea C, Amado-Rodriguez L, Lopez-Alonso I . Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome. Gene. 2020; 762:145102. PMC: 7456966. DOI: 10.1016/j.gene.2020.145102. View